When you offer phenomenal service, an unrivalled pharma portfolio, and take a global yet personal approach with fantastic partners, it’s only a matter of time before you need to expand.

The countdown has officially started!

We have been quietly working behind the scenes on our new state of the art, ultra-modern lab capable of handling even the most highly potent drugs. We’ve already been GMP inspected by the local state authority, and we’re very nearly ready to welcome our first projects.

Spanning over 500m2, the additional site promises the same level of regulatory rules, standard operating procedures and excellent service as our flagship Prague HQ, and with logistics between the two locations already well established there is no doubt that this expansion will provide the extra capacity needed as Quinta continues to grow.

Excited to hear more about this very special new lab and learn where it’s based? Watch this space!

Also, be sure to follow us on LinkedIn for the latest news and greatest announcements in the pharma industry.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.